
FDA's review identified severe DRESS cases worldwide, with hospitalization and fatalities, supporting a link to levetiracetam and clobazam. Discontinuation often leads to symptom improvement. Patients and caregivers are urged not to abruptly stop taking levetiracetam or clobazam without consulting healthcare professionals to avoid uncontrolled seizures. Immediate medical attention is crucial for Drug Reactions with Eosinophilia and Systemic Symptoms (DRESS). Individuals should promptly visit an emergency room if unusual symptoms or reactions, including a rash, occur during levetiracetam or clobazam use. DRESS symptoms, like fever and swollen lymph nodes, may manifest 2 to 8 weeks after starting the medication. Healthcare professionals must promptly recognize and treat DRESS, emphasizing patient education on symptoms and discontinuation.
Like
Save
Share